|Author:||Lam, Ka Wai Ricky|
|Title:||Analysis of effects of cell wall active antibiotics towards development of vancomycin non-susceptibility in methicillin-resistance Staphylococcus aureus|
Hong Kong Polytechnic University -- Dissertations
|Department:||Department of Health Technology and Informatics|
|Pages:||xii, 120 leaves : ill. (some col.) ; 30 cm.|
|Abstract:||Methicillin-resistant Staphylococcus aureus (MRSA) is a well known pathogen associated with hospital acquired and community infection. Vancomycin is the mainstay to treat MRSA infection, but non-susceptible strains have been reported since 1997 in Japan. Although having low prevalence, these resistant strains known as vancomycin intermediate S. aureus (VISA) and heterogeneous vancomycin intermediate S. aureus (h-VISA), were a problem for treatment and laboratory detection. There are many studies explaining the features of cell wall thickening and genetic mutations of two-component regulatory system (TCRS) vraSR and graRS, associated with VISA. Thickened cell wall causes the slowing of diffusion of the vancomycin molecule to the target site. Genetic mutation stimulates cell wall synthesis and is associated with the increase of vancomycin minimum inhibitory concentration. In this study, vancomycin non-susceptible S. aureus were induced under selection using a variety of cell wall active antibiotics. Sequencing of vraS and graR genes were compared with their susceptible parent strains for genome analysis. From the results, all antimicrobial agents used (vancomycin, cefotaxime, rifampin and ciprofloxacin) were found to show induced effect to vancomycin non-susceptibility. Non-cell wall active agent, Ciprofloxacin was found to show the lowest effect on vancomycin non-susceptibility and did not induce a VISA phenotype. Additionally, there was no significant change of Bacitracin susceptibility results demonstrated by all drug induced strains. Finally, we have identified vraS and graR mutations in the sequence of derived strains, respectively, were found to be associated with the development of vancomycin non-susceptibility in methicillin-resistance S. aureus. This suggests combine effect of vancomycin and other groups of antimicrobial agents have low likelihood to combat against MRSA infection.|
|Rights:||All rights reserved|
Files in This Item:
|b25514854.pdf||For All Users (off-campus access for PolyU Staff & Students only)||1.39 MB||Adobe PDF||View/Open|
As a bona fide Library user, I declare that:
- I will abide by the rules and legal ordinances governing copyright regarding the use of the Database.
- I will use the Database for the purpose of my research or private study only and not for circulation or further reproduction or any other purpose.
- I agree to indemnify and hold the University harmless from and against any loss, damage, cost, liability or expenses arising from copyright infringement or unauthorized usage.
By downloading any item(s) listed above, you acknowledge that you have read and understood the copyright undertaking as stated above, and agree to be bound by all of its terms.
Please use this identifier to cite or link to this item: